Saltar al contenido
Merck

Clinical practice: Acute high-altitude illnesses.

The New England journal of medicine (2013-06-14)
Peter Bärtsch, Erik R Swenson
RESUMEN

A 45-year-old healthy man wishes to climb Mount Kilimanjaro (5895 m) in a 5-day period, starting at 1800 m. The results of a recent exercise stress test were normal; he runs 10 km 4 or 5 times per week and finished a marathon in less than 4 hours last year. He wants to know how he can prevent becoming ill at high altitude and whether training or sleeping under normobaric hypoxic conditions in the weeks before the ascent would be helpful. What would you advise?

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Dexametasona, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Dexamethasone-Water Soluble, suitable for cell culture, BioReagent
Sigma-Aldrich
Dexametasona, ≥98% (HPLC), powder
Sigma-Aldrich
Dexametasona, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
Acetazolamide, ≥99%, powder
Sigma-Aldrich
Dexametasona, meets USP testing specifications
Sigma-Aldrich
Dexametasona, tested according to Ph. Eur.
Dexametasona, European Pharmacopoeia (EP) Reference Standard
Supelco
Dexametasona, VETRANAL®, analytical standard
Acetazolamide, European Pharmacopoeia (EP) Reference Standard